Truist Financial Lowers OrthoPediatrics (NASDAQ:KIDS) Price Target to $25.00

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) had its price objective decreased by equities research analysts at Truist Financial from $28.00 to $25.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a "hold" rating on the stock. Truist Financial's price objective suggests a potential upside of 11.96% from the stock's current price.

Several other research firms have also recently weighed in on KIDS. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Friday, November 8th. JMP Securities reiterated a "market outperform" rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Trading Down 0.6 %

NASDAQ:KIDS traded down $0.13 during trading hours on Wednesday, hitting $22.33. The company had a trading volume of 259,307 shares, compared to its average volume of 174,011. OrthoPediatrics has a 1 year low of $21.02 and a 1 year high of $36.23. The company has a market cap of $540.74 million, a P/E ratio of -18.15 and a beta of 1.14. The company has a 50-day moving average of $25.38 and a 200 day moving average of $28.30. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19.

Institutional Investors Weigh In On OrthoPediatrics

Institutional investors and hedge funds have recently modified their holdings of the company. SG Americas Securities LLC acquired a new position in shares of OrthoPediatrics in the second quarter worth $110,000. Bank of New York Mellon Corp increased its holdings in OrthoPediatrics by 14.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 68,700 shares of the company's stock worth $1,976,000 after purchasing an additional 8,887 shares during the period. Commonwealth Equity Services LLC raised its position in OrthoPediatrics by 0.6% in the 2nd quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company's stock valued at $2,098,000 after purchasing an additional 420 shares in the last quarter. Triodos Investment Management BV increased its holdings in OrthoPediatrics by 1.2% in the second quarter. Triodos Investment Management BV now owns 41,500 shares of the company's stock valued at $1,194,000 after buying an additional 500 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in OrthoPediatrics by 19.0% in the second quarter. Rhumbline Advisers now owns 26,613 shares of the company's stock valued at $765,000 after buying an additional 4,245 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company's stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.